U.S. health agencies have called for Johnson & Johnson to be discontinued
U.S. health agencies have called for a halt to the spread of the Johnson & Johnson vaccine while investigating various incidents of blood clots.
In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they were studying six cases of “rare and severe” blood clots in people who received the J&J vaccine. Individuals were women between the ages of 18 and 48 who were vaccinated and developed symptoms within 6 to 13 days.
Nearly 7m doses of J&J owner have been administered in the US.
The CDC said it will consider the cases at a meeting of the advisory committee on vaccine practices on Wednesday, while the FDA investigates the importance of blood clots.
“Until this process is completed, we recommend pausing the use of this vaccine to be careful,” they said, adding that it is important for health authorities to understand and plan treatment for a particular type of blood clot. .
J&J said it continues to work closely with experts and regulators to evaluate the data.
“We know that thrombocytopenia events such as those with thrombocytopenia with Covid-19 vaccines have been reported. There is currently no clear causal relationship between these rare events and the Janssen Covid-19 vaccine,” he said.
The call to expand the J&J vaccine for fears of a blood clot follows similar issues with the Oxford / AstraZeneca owner.
The J&J shot is also approved in the EU and is scheduled for Wednesday. The European Medicines Agency, which examines certain cases of blood clots in people who received the J&J vaccine, did not immediately respond to a response request. So far he has said there is no evidence of a causal link.
Additional reports by Hannah Kuchler and Donato Paolo Mancini